It’s a strange email. How the heck don’t the know the data? It was unlocked last week and he’s talking about parsing through it. This is the weirdest trial unveiling I’ve ever witnessed, replete with CEO replying to rando shareholders who then post to whacky IHub mayhem at the zero hour. This is not normal CEO behavior not normal pharma behavior. Let’s hope they just meet their damn primary endpoint and get a $ deal ASAP.
News 
Market Data 
Discover 
